Naji LEHBIB MD

An implantable loop recorder (ILR) can be a game-changer in these 3 cases:
✅ Cryptogenic stroke
✅ Unexplained syncope after negative workup
✅ Infrequent unexplained palpitations

Long-term rhythm monitoring makes all the difference. #CardioEd #Cardio_Sky
@heartrhythmsociety.bsky.social

An implantable loop recorder (ILR) can be a game-changer in these 3 cases:
✅ Cryptogenic stroke
✅ Unexplained syncope after negative workup
✅ Infrequent unexplained palpitations

Long-term rhythm monitoring makes all the difference. #CardioEd #Cardio_Sky
@heartrhythmsociety.bsky.social

#HeartFailure2025

#cardiosky #medsky #med_ed
#echo_first #why_CMR

Super Helpful 👌
#cardiosky #medical_education #med_ed

Bottom line:
TAVR is proving safe, effective, and durable—even in low-risk patients.
ALIGN-AR opens doors for AR patients with no prior transcatheter options and high surgical risk.
#ACC25

Evolut Low Risk Trial:
TAVR vs. Surgery in patients with severe aortic stenosis + low surgical risk.
5-year outcomes:

TAVR = surgery in death/stroke

Better valve performance with TAVR

Durable quality of life
#ACC25

Why ALIGN-AR matters:
There’s currently NO FDA-approved transcatheter valve for native AR in the US.
This trial could lead to the first dedicated solution for high-risk AR patients.
#ACC25

ALIGN-AR Trial:
First major study focused specifically on high-risk patients with severe aortic regurgitation.
Device: JenaValve Trilogy THV
Result: >95% device success, low 30-day mortality & stroke, improved symptoms.
A game-changer for a previously untreatable group.
#ACC25

Big moves in structural heart disease! Two landmark trials—ALIGN-AR and Evolut Low Risk— from #ACC25 are shaping the future of aortic valve therapy. Quick breakdown:

Can't wait to read your book @gbiondizoccai.bsky.social
The photo is terrific by the way.

Opinion | The Warm-Up Hack Doctors Should Take From Pop Stars and Quarterbacks Doctors need to warm up too.

Coaching before high-stakes medical procedures could save lives, but implementation faces hurdles: time, workflow, and tradition.
Would the cultural and logistical shifts necessary be possible?

An interesting opinion piece from the @nytimes.com
#CardioSky #MedSky

www.nytimes.com/2025/01/06/o...

● Think about cardiac metastasis in cancer patients with LVH.
● Secondary cardiac tumors way more common than primary.
● Symptoms: nonspecific, leading to delayed diagnosis.
● CMR is the gold standard for tissue characterization and tumor diagnosis.

#whyCMR #CardioSky #MedSky

Waiting periods and available places in our rehab centers are obviously a major obstacle.

Was there an associated aneurysm? If yes did the patient present signs of ischaemia related to possible compression?

It's great to see this progress. Happy to be part of this new community.

Thank you.

I just learned about the new platform from a Twitter post. Migration ongoing. It's true that X is becoming too distracting.

Just learned about the BlueSky migration through this post. And i confirm that Twitter or X became too distracting for us scientists looking mainly to exchange with our peers throughout the world. So I'm migrating too.
#CardioSky #MedSky #MedEd